Pappas Ana Lucia, Fluder Elaine M, Creech Steve, Hotaling Andrew, Park Albert
*Department of Anesthesiology, †Department of Otolaryngology-Head and Neck Surgery, Loyola University Medical Center, Maywood, Illinois.
Anesth Analg. 2003 Jun;96(6):1621-1624. doi: 10.1213/01.ANE.0000064206.51296.1D.
We enrolled 120 children undergoing bilateral myringotomy and tube placement in this prospective, randomized, observer-blinded study. Patients were randomized into one of four groups: Group 1 (control) was plain acetaminophen 10 mg/kg orally, Group 2 was acetaminophen 10 mg/kg with 1 mg/kg of codeine orally, Group 3 was transnasal butorphanol 25 micro g/kg given immediately after the induction of anesthesia, and Group 4 was ketorolac 1 mg/kg given IM immediately after the induction of anesthesia. All children received oral midazolam (0.6 mg/kg) before surgery. A nurse blinded to the analgesic technique used assessed the child's behavior at the induction of anesthesia and in the postanesthesia care unit using a 4-point scale. Analgesic effectiveness was determined by assessing the child's pain at 5-min intervals using a modified 10-point objective pain scale. In the postanesthesia care unit, rescue pain medication was administered for an objective pain scale >or=4 or a behavior score >or=3. Our data suggest that IM ketorolac is a promising analgesic to be used in this surgical population. Time to first rescue analgesic was longest in the ketorolac group, and there was no associated postoperative vomiting or nausea. IM ketorolac given during surgery was the best analgesic regimen for these procedures.
We compared four different analgesics in the management of pain after placement of pressure equalization tubes during myringotomy in children and demonstrated that ketorolac or butorphanol provided superior analgesia when compared with acetaminophen with codeine or plain acetaminophen. Children who received ketorolac versus butorphanol had less vomiting in the 24 h after surgery.
在这项前瞻性、随机、观察者盲法研究中,我们纳入了120名接受双侧鼓膜切开置管术的儿童。患者被随机分为四组:第1组(对照组)口服普通对乙酰氨基酚10 mg/kg,第2组口服对乙酰氨基酚10 mg/kg加可待因1 mg/kg,第3组在麻醉诱导后立即经鼻给予布托啡诺25 μg/kg,第4组在麻醉诱导后立即肌内注射酮咯酸1 mg/kg。所有儿童在手术前均口服咪达唑仑(0.6 mg/kg)。一名对所采用的镇痛技术不知情的护士使用4分制量表评估儿童在麻醉诱导时及麻醉后护理单元的行为。通过使用改良的10分客观疼痛量表每隔5分钟评估一次儿童的疼痛来确定镇痛效果。在麻醉后护理单元,当客观疼痛量表≥4或行为评分≥3时给予解救性止痛药物。我们的数据表明,肌内注射酮咯酸是一种有前景的可用于该手术人群的镇痛药。酮咯酸组首次使用解救性镇痛药的时间最长,且无相关的术后呕吐或恶心。手术期间肌内注射酮咯酸是这些手术的最佳镇痛方案。
我们比较了四种不同的镇痛药用于儿童鼓膜切开术期间放置通气管后疼痛的管理,结果表明与含可待因的对乙酰氨基酚或普通对乙酰氨基酚相比,酮咯酸或布托啡诺提供了更好的镇痛效果。接受酮咯酸与布托啡诺治疗的儿童在术后24小时内呕吐较少。